IL6 and sarcopenia: Inflammatory cytokines (e.g., TNF-α, IL-6) activate NF-κB and MAPK signaling pathways, exacerb muscle protein degradation and suppressing synthesis, thereby directly promoting sarcopenia (42, 43).